Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 11;19(1):369.
doi: 10.1186/s13063-018-2756-7.

Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial

Suguru Yamada  1 , Tsutomu Fujii  2 , Manabu Kawai  3 , Toshio Shimokawa  4 , Masafumi Nakamura  5 , Yoshiaki Murakami  6 , Sohei Satoi  7 , Hidetoshi Eguchi  8 , Yuichi Nagakawa  9 , Yasuhiro Kodera  1 , Hiroki Yamaue  10
Affiliations

Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial

Suguru Yamada et al. Trials. .

Abstract

Background: In distal pancreatectomy (DP), it is customary to ligate and divide the splenic vein after isolating it from the pancreatic parenchyma. This is considered essential to prevent disruption of the stump of the splenic vein and consequent intra-abdominal haemorrhage in the event of pancreatic fistula (PF). However, this procedure can be technically demanding, especially when the vein is firmly embedded in the pancreatic parenchyma. The objective of the COSMOS-DP trial is to confirm the non-inferiority of resection of the splenic vein embedded in the pancreatic parenchyma compared with the conventional technique of isolating the splenic vein before resection during DP using a mechanical stapler.

Methods: Patients with diseases of the pancreatic body and tail whose pancreatic parenchyma and splenic vein can be divided concurrently during open or laparoscopic DP are considered eligible for inclusion. This study is designed as a multicentre prospective randomised phase III trial. Eligible patients will be centrally randomised to either Arm A (resection of the splenic vein after isolation from the pancreatic parenchyma) or Arm B (co-resection of the vein together with the pancreas). This study aims to establish the non-inferiority of the safety of Arm B compared with that of Arm A; the primary endpoint is the incidence of PF (ISGPF grade B/C).

Discussion: The COSMOS-DP trial will establish the safety of this procedure, such that it can be recommended with more confidence. The use of this procedure will likely result in significant reductions in operative time and blood loss during DP.

Trial registration: ClinicalTrials.gov, NCT02871804 . Registered on 27 July 2016.

Keywords: Distal pancreatectomy; Intra-abdominal haemorrhage; Mechanical stapler; Pancreatic fistula; Splenic vein.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study will be conducted according to the Declaration of Helsinki (Fortaleza, Brazil, October 2013) and ethical guidelines for medical and health research involving human subjects in Japan. Written informed consent approved by the Institutional Review Board will be obtained from all of the enrolled patients. Ethical approval for this study was obtained by the Institutional Review Board of each institution.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow diagram of COSMOS-DP trial
Fig. 2
Fig. 2
Study calendar
See this image and copyright information in PMC

References

    1. Olah A, Issekutz A, Belagyi T, Hajdu N, Romics L., Jr Randomized clinical trial of techniques for closure of the pancreatic remnant following distal pancreatectomy. Br J Surg. 2009;96:602–607. doi: 10.1002/bjs.6620. - DOI - PubMed
    1. Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011;377:1514–1522. doi: 10.1016/S0140-6736(11)60237-7. - DOI - PubMed
    1. Takahashi H, Ogawa H, Ohigashi H, Gotoh K, Yamada T, Ohue M, et al. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma. Surgery. 2011;150:547–556. doi: 10.1016/j.surg.2011.03.001. - DOI - PubMed
    1. Frozanpor F, Lundell L, Segersvard R, Arnelo U. The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg. 2012;255:1032–1036. doi: 10.1097/SLA.0b013e318251610f. - DOI - PubMed
    1. Carter TI, Fong ZV, Hyslop T, Lavu H, Tan WP, Hardacre J, et al. A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg. 2013;17:102–109. doi: 10.1007/s11605-012-1963-x. - DOI - PubMed

Publication types

MeSH terms

Associated data